According to AlphaMoat, in October 2026 Nabla Bio (nabla.bio) received 3,106 monthly visits (-56% MoM) — ranked #13,862 of 17,609 AI websites with traffic data, and #2,323 of 3,112 in Industry Services; its largest market is United States (100.0% of visits).
What is Nabla Bio
Nabla Bio serves pharmaceutical companies; according to its official website, it conducts drug design with generative AI, combined with patient-relevant experimental validation, turning drug development into a designable discipline and accelerating new drug discovery.
- 01Generative drug design
- 02large-scale parallel experimental validation
- 03integration of AI and laboratory technologies
- 04targeting challenging disease targets
12-Month Traffic Trend
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-07 | 8.8K | — |
| 2026-08 | 6.7K | -24.0% |
| 2026-09 | 7.1K | +5.3% |
| 2026-10 | 3.1K | -56.0% |
Visits by Country · Top 5
Popular in Industry Services
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ Compare
A platform connecting specialists with model research, training, and evaluation projects
+ Compare
A conversational hiring agent that moves candidates from application through onboarding
+ Compare
A talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ Compare
A clinician platform combining communication, telehealth, and AI-assisted documentation
+ Compare
An AI research and search platform built for professional investors
+ CompareFAQ
How many monthly visits does Nabla Bio get?
According to AlphaMoat, Nabla Bio (nabla.bio) received 3,106 visits (about 3.1K) in October 2026 (-56% month over month), ranking #13,862 of 17,609 AI websites with traffic data, and #2323 in Industry Services.
What are some alternatives to Nabla Bio?
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.